Quantitative assessment of regional myocardial blood flow using oxygen- 15-labelled water and positron emission tomography: A multicentre evaluation in Japan

European Journal of Nuclear Medicine

Volumn 27, Issue 2, 2000, Pages 192-201

  Iida, Hidehiro ^a,b   Yokoyama, Ikuo ^c   Agostini, Denis ^a   Banno, Tatsuo ^c   Kato, Takashi ^c   Ito, Kengo ^c   Kuwabara, Yasuo ^c   Oda, Yohei ^c   Otake, Tohru ^c   Tamura, Yoshikazu ^a   Tadamura, Eiji ^c   Yoshida, Tsuyoshi ^c   Tamaki, Nagara ^c  

^a RESEARCH INSTITUTE FOR BRAIN AND BLOOD VESSELS AKITA   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^c NONE

Author keywords

Multicentre study; Oxygen 15 labelled water; Positron emission tomography; Regional myocardial blood flow

Indexed keywords

DIPYRIDAMOLE; OXYGEN 15; WATER;

ACCURACY; ADULT; ARTICLE; CLINICAL TRIAL; HEART MUSCLE BLOOD FLOW; HEMODYNAMICS; HUMAN; JAPAN; MALE; MEASUREMENT; MULTICENTER STUDY; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY;

EID: 0033966625     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050026     Document Type: Article

References (51)

1. 1. Uren NG, Melin JA, De Bruyne B, Wijns W, Baudhuin T, Camici PG. Relation between myocardial blood flow and the severity of coronary artery stenosis. N Engl J Med 1994; 330: 1782-1788.
2. 2. Uren NG, Marraccini P, Gistri R, de Silva R, Camici PG. Altered coronary vasodilator reserve and metabolism in myocardium subtended by normal arteries in patients with coronary artery disease. J Am Coll Cardiol 1993; 22: 650-658.
3. 3. Di Carli M, Czernin J, Hoh CK, et al. Relation among stenosis severity, myocardial blood flow, and flow reserve in patients with coronary artery disease. Circulation 1995; 91: 1944-1951.
4. 4. Yokoyama I, Murakami T, Ohtake T, et al. Reduced coronary flow reserve in familial hypercholesterolemia. J Nucl Med 1996; 37: 1937-1942.
5. 5. Yokoyama I, Momomura S, Ohtake T, et al. Reduced myocardial flow reserve in non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 1997; 30: 1472-1477.
6. 6. Dayanikli F, Grambow D, Muzik O, Mosca L, Rubenfire M, Schwaiger M. Early detection of abnormal coronary flow reserve in asymptomatic men at high risk for coronary artery disease using positron emission tomography. Circulation 1994; 90: 808-817.
7. 7. Pitkanen OP, Raitakari OT, Niinikoski H, et al. Coronary flow reserve is impaired in young men with familial hypercholesterolemia. J Am Coll Cardiol 1996; 28: 1705-1711.
8. 8. Laine H, Raitakari OT, Niinikoski H, et al. Early impairment of coronary flow reserve in young men with borderline hypertension. J Am Coll Cardiol 1998; 32: 147-153.
9. 9. Yokoyama I, Ohtake T, Momomura S, Nishikawa J, Sasaki Y, Omata M. Reduced coronary flow reserve in hypercholesterolemic patients without overt coronary stenosis. Circulation 1996; 94: 3232-3238.
10. 10. Yokoyama I, Ohtake T, Momomura S, et al. Hyperglycemia rather than insulin resistance is related to reduced coronary flow reserve in NIDDM. Diabetes 1998; 47: 119-124.
11. 11. Nitenberg A, Valensi P, Sachs R, Dali M, Aptecar E, Attali JR. Impairment of coronary vascular reserve and ACh-induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function. Diabetes 1993; 42: 1017-1025.
12. 12. Nitenberg A, Paycha F, Ledoux S, Sachs R, Attali JR, Valensi P. Coronary artery responses to physiological stimuli are improved by deferoxamine but not by L-arginine in non-insulin-dependent diabetic patients with angiographically normal coronary arteries and no other risk factors. Circulation 1998; 97: 736-743.
13. 13. Nahser PJ Jr., Brown RE, Oskarsson H, Winniford MD, Rossen JD. Maximal coronary flow reserve and metabolic coronary vasodilation in patients with diabetes mellitus. Circulation 1995; 91: 635-640.
14. 14. Strauer BE, Motz W, Vogt M, Schwartzkopff B. Impaired coronary flow reserve in NIDDM: a possible role for diabetic cardiopathy in humans. Diabetes 1997; 46: S119-S124.
15. 15. Strauer BE, Motz W, Vogt M, Schwartzkopff B. Evidence for reduced coronary flow reserve in patients with insulin-dependent diabetes, a possible cause for diabetic heart disease in man. Exp Clin Endocrinol Diabetes 1997; 105: 15-20.
16. 16. Gould KL, Martucci JP, Goldberg DI, et al. Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary artery disease. A potential noninvasive marker of healing coronary endothelium. Circulation 1994; 89: 1530-1538.
17. 17. Gould KL, Ornish D, Scherwitz L, et al. Changes in myocardial perfusion abnormalities by positron emission tomography after long-term, intense risk factor modification. JAMA 1995; 274: 894-901.
18. 18. Czernin J, Barnard RJ, Sun KT, et al. Effect of short-term cardiovascular conditioning and low-fat diet on myocardial blood flow and flow reserve. Circulation 1995; 92: 197-204.
19. 19. Yokoyama I, Ohtake T, Yonekura K, et al. Improvement of reduced coronary flow reserve in angiographically normal coronary arteries in hypercholesterolemics after lipid lowering therapy [abstract]. J Nucl Med 1997; 38: 85p.
20. 20. Schelbert HR, Phelps ME, Huang SC, et al. N-13 ammonia as an indicator of myocardial blood flow. Circulation 1981; 63: 1259-1272.
21. 13N ammonia myocardial imaging at rest and with exercise in normal volunteers. Quantification of absolute myocardial perfusion with dynamic positron emission tomography. Circulation 1989; 80: 1328-1337.
22. 22. Krivokapich J, Stevenson LW, Kobashigawa J, Huang SC, Schelbert HR. Quantification of absolute myocardial perfusion at rest and during exercise with positron emission tomography after human cardiac transplantation. J Am Coll Cardiol 1991; 18: 512-517.
23. 13N-ammonia and reoriented dynamic positron emission tomographic imaging. Circulation 1992; 86: 1004-1017.
24. 24. Hutchins GD, Schwaiger M, Rosenspire KC, Krivokapich J, Schelbert H, Kuhl DE. Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging. J Am Coll Cardiol 1990; 15: 1032-1042.
25. 25. Araujo LI, Lammertsma AA, Rhodes CG, et al. Noninvasive quantification of regional myocardial blood flow in coronary artery disease with oxygen-15-labeled carbon dioxide inhalation and positron emission tomography. Circulation 1991; 83: 875-885.
26. 26. Bergmann SR, Herrero P, Markham J, Weinheimer CJ, Walsh MN. Noninvasive quantitation of myocardial blood flow in human subjects with oxygen-15-labeled water and positron emission tomography. J Am Coll Cardiol 1989; 14: 639-652.
27. 15O and dynamic positron-emission tomography. Strategy for quantification in relation to the partial-volume effect. Circulation 1988; 78: 104-115.
28. 28. Iida H, Takahashi A, Tamura Y, Ono Y, Lammertsma AA. Myocardial blood flow: comparison of oxygen-15-water bolus injection, slow infusion and oxygen-15-carbon dioxide slow inhalation. J Nucl Med 1995; 36: 78-85.
29. 29. Iida H, Miura S, Shoji Y, et al. Noninvasive quantitation of cerebral blood flow using oxygen-15-water and a dual-PET system. J Nucl Med 1998; 39: 1789-1798.
30. 30. Hermansen F, Rosen SD, Fath-Ordoubadi F, et al. Measurement of myocardial blood flow with oxygen-15 labelled water: comparison of different administration protocols. Eur J Nucl Med 1998; 25: 751-759.
31. 31. Muzik O, Beanlands RS, Hutchins GD, Mangner TJ, Nguyen N, Schwaiger M. Validation of nitrogen-13-ammonia tracer kinetic model for quantification of myocardial blood flow using PET. J Nucl Med 1993; 34: 83-91.
32. 15O]water techniques. Circulation 1996; 93: 2000-2006.
33. 15O]water estimates of perfusion with quantification of regional myocardial blood flow by microspheres. Circulation 1993; 87: 512-525.
34. 34. Wisenberg G, Schelbert HR, Hoffman EJ, et al. In vivo quantitation of regional myocardial blood flow by positron-emission computed tomography. Circulation 1981; 63: 1248-1258.
35. 35. Henze E, Huang SC, Ratib O, Hoffman E, Phelps ME, Schelbert HR. Measurements of regional tissue and blood-pool radiotracer concentrations from serial tomographic images of the heart. J Nucl Med 1983; 24: 987-996.
36. 36. Iida H, Rhodes CG, de Silva R, et al. Myocardial tissue fraction-correction for partial volume effects and measure of tissue viability. J Nucl Med 1991; 32: 2169-2175.
37. 37. Hermansen F, Ashburner J, Spinks TJ, Kooner JS, Camici PG, Lammertsma AA. Generation of myocardial factor images directly from the dynamic oxygen-15-water scan without use of an oxygen-15-carbon monoxide blood-pool scan. J Nucl Med 1998; 39: 1696-1702.
38. 38. Kanno I, Miura S, Yamamoto S, et al. Design and evaluation of a positron emission tomograph: Headtome-III. J Comput Assist Tomogr 1985; 9: 931-939.
39. 39. Iida H, Miura S, Kanno I, Murakami M, Takahashi K, Uemura K. Design and evaluation of headtome-IV, a whole-body positron emission tomograph. IEEE Trans Nucl Sci 1989; 36: 1006-1110.
40. 40. Tamaki N, Magata Y, Takahashi N, et al. Oxidative metabolism in the myocardium in normal subjects during dobutamine infusion. Eur J Nucl Med 1993; 20: 231-237.
41. 41. Iida H, Rhodes CG, de Silva R, et al. Use of the left ventricular time-activity curve as a noninvasive input function in dynamic oxygen-15-water positron emission tomography. J Nucl Med 1992; 33: 1669-1677.
42. 42. Senneff MJ, Geltman EM, Bergmann SR. Noninvasive delineation of the effects of moderate aging on myocardial perfusion [published erratum appears in J Nucl Med 1992; 33: 201]. J Nucl Med 1991; 32: 2037-2042.
43. 43. Uren NG, Camici PG, Melin JA, et al. Effect of aging on myocardial perfusion reserve. J Nucl Med 1995; 36: 2032-2036.
44. 44. Bottcher M, Czernin J, Sun KT, Phelps ME, Schelbert HR. Effect of caffeine on myocardial blood flow at rest and during pharmacological vasodilation. J Nucl Med 1995; 36: 2016-2021.
45. 45. Czernin J, Sun K, Brunken R, Bottcher M, Phelps M, Schelbert H. Effect of acute and long-term smoking on myocardial blood flow and flow reserve. Circulation 1995; 91: 2891-2897.
46. 15O-water and dynamic positron emission tomography. Circulation 1992; 86: 167-178.
47. 47. de Silva R, Yamamoto Y, Rhodes CG, et al. Preoperative prediction of the outcome of coronary revascularization using positron emission tomography. Circulation 1992; 86: 1738-1742.
48. 48. Gerber BL, Melin JA, Bol A, et al. Nitrogen-13-ammonia and oxygen-15-water estimates of absolute myocardial perfusion in left ventricular ischemic dysfunction. J Nucl Med 1998; 39: 1655-1662.
49. 49. Iida H, Miura S, Shoji Y, et al. Noninvasive quantitation of cerebral blood flow using oxygen-15-water and a dual-PET system. J Nucl Med 1998; 39: 1789-1798.
50. 50. Katoh C, Ruotsalainen U, Laine H, et al. A new iterative reconstruction method based on median filter root in quantification of myocardial blood flow and oxygen metabolism with PET. J Nucl Med 1999; 40: 862-867.
51. 51. Strother S, Casey M, Hoffman E. Measuring PET scanner sensitivity: relating countrates to image signal-to-noise ratios using noise equivalent counts. IEEE Trans Nucl Sci 1990; 37: 783-788.